Literature DB >> 7368937

Trabecular bone mineralization lag time determined by tetracycline double-labeling in normal and certain pathological conditions.

F Melsen, L Mosekilde.   

Abstract

Quantitative histomorphometric analyses of iliac crest biopsy specimens were performed after tetracycline double-labeling in 41 normal individuals, 20 hyper- and 10 hypothyroid patients, 18 patients with primary hyperparathyroidism, 20 epileptic patients receiving long-term anticonvulsant therapy, and 17 patients after jejunoileal bypass for morbid obesity. The mineralization lag time in trabecular bone or the period of time between apposition and subsequent mineralization of osteoid was calculated from the bone formation rate at BMU level (Basic Multicellular Unit) and the mean width of osteoid seams. The mineralization lag time was 8-52 days (median 21 days) in normal individuals and showed no variation with sex or age. The mineralization lag time was shortened in hyperthyroidism, normal in anticonvulsant bone disease and in primary hyperparathyroidism, and markedly prolonged in hypothyroidism and following jejunoileal bypass. Among all individuals an inverse hyperbolic relation (r = 0.94, p less than 0.001) was found between the mineralization lag time and the average cellular activity of the osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7368937     DOI: 10.1111/j.1699-0463.1980.tb02470.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  11 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

2.  A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.

Authors:  Erno van Schaick; Jenny Zheng; Juan Jose Perez Ruixo; Ronald Gieschke; Philippe Jacqmin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-06-30       Impact factor: 2.745

3.  Effects of ossein-hydroxyapatite compound on ewe bone remodeling: biochemical and histomorphometric study.

Authors:  P Chavassieux; P Pastoureau; G Boivin; P D Delmas; M C Chapuy; P J Meunier
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

4.  Effect of serum 25-hydroxyvitamin D concentrations on skeletal mineralization in black and white women.

Authors:  Shijing Qiu; Sudhaker D Rao
Journal:  J Bone Miner Metab       Date:  2021-06-14       Impact factor: 2.626

Review 5.  Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

Authors:  Martha Blank; Natalie A Sims
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

6.  Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women.

Authors:  M E Arlot; P D Delmas; D Chappard; P J Meunier
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

Review 7.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

8.  Fluoride-induced bone changes in lambs during and after exposure to sodium fluoride.

Authors:  P Chavassieux; P Pastoureau; G Boivin; M C Chapuy; P D Delmas; G Milhaud; P J Meunier
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

9.  Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study.

Authors:  P Chavassieux; P Pastoureau; M C Chapuy; P D Delmas; P J Meunier
Journal:  Osteoporos Int       Date:  1993-03       Impact factor: 4.507

10.  Metabolic and clinical consequences of hyperthyroidism on bone density.

Authors:  Jagoda Gorka; Regina M Taylor-Gjevre; Terra Arnason
Journal:  Int J Endocrinol       Date:  2013-07-22       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.